It acts as a potent “eat-me” signal, engaging CD91 receptors on phagocytes such as dendritic cells and macrophages, thereby promoting the phagocytosis of tumor cell corpses and subsequent cross-presentation of tumor antigens to CD8+ T cells [43,45]. The gene discussed is CD8A; the disease is neoplasm.